Abstract
Aging-related hearing loss (ARHL) is epidemiologically linked to the development of Alzheimer’s Disease (AD). The mechanisms underlying this relationship are not known and have important therapeutic implications. If ARHL is causally linked to the development of AD, then correction of hearing loss via hearing aids should mitigate cognitive impairments in AD and more aggressive campaigns to treat ARHL, which is widely undertreated, would be warranted. Here, we critically examine the literature involving the use of hearing aids to treat ARHL and examine the impact of hearing aids on cognition. Although many studies report beneficial effects of hearing aids on cognition, most of these studies have significant flaws in their experimental design, making it difficult to judge their outcomes. In our selection process, we prioritized randomized studies and those with blinded and placebo-controlled outcomes. We evaluated a total of 10 papers that met inclusion criteria. Within our literature review, we found two randomized placebo-controlled studies that examined the impact of hearing aids on cognition in cognitively-impaired or vulnerable older individuals with minimal risk of bias. Meta-analysis of these two studies did not yield a statistically significant benefit of hearing aid use after 6 or 12 months of use. We propose that the current literature on this topic currently lacks compelling evidence to demonstrate that hearing aid use directly benefits cognition or delays AD. We further recommend strategies for improving clinical trial design to bring greater clarity to this important issue.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All source data were openly available in peer-reviewed publications.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Disclaimer: The authors declare no conflicts of interest
Data Availability
All data produced in the present study are available upon reasonable request to the authors
